The Goldman Sachs Group has raised its price target for Old Dominion Freight Line (NASDAQ:ODFL) to $198.00, maintaining a "buy" rating despite implying a slight downside from the current share price. This adjustment comes amidst mixed analyst views, with an overall "Hold" consensus and an average target of $195.50. Old Dominion Freight Line recently beat earnings per share and revenue expectations for the quarter, though revenue saw a year-over-year decline.

Stifel Nicolaus has increased its price target for Old Dominion Freight Line (NASDAQ:ODFL) to $228 from $217, maintaining a "buy" rating with an implied upside of 11.12%. Despite a mixed analyst consensus of "Hold" and a $195.50 price target, and recent insider sales totalings $15.64 million, the company recently beat EPS estimates, though revenue declined by 5.7% year-over-year.

Charles Schwab is rolling out "Schwab Crypto," a new service allowing retail clients to directly trade bitcoin and ethereum. This offering integrates crypto trading with traditional investments, providing educational resources, professional support, and competitive pricing. The service will be phased in, with plans to add more cryptocurrencies and transfer capabilities in the future.

Barclays has increased its price target for CF Industries (NYSE:CF) to $130.00 from $120.00, maintaining an "overweight" rating, which suggests a potential upside of 7.74%. This comes after CF Industries reported strong quarterly earnings, beating analyst expectations with $2.59 EPS and $1.87 billion in revenue. Despite a consensus "Hold" rating from analysts with an average target of $114.87, some firms like Morgan Stanley have issued higher targets, while insiders have recently sold a notable volume of shares.

Bank of Montreal (BMO) has issued £1 billion of floating rate covered bonds due in April 2029 under its global covered bond program. These bonds will be traded in the UK, aiming to diversify BMO's funding sources and enhance its presence in European capital markets. This move highlights the bank's strategy to expand its international footprint and meet institutional investor demand for high-grade, secured debt instruments.

Prologis Inc (NYSE: PLD) has reached a 52-week high of $144.05, with shares currently trading at $144.37, marking a 44.21% increase over the past year. Despite appearing overvalued by InvestingPro's Fair Value analysis with a P/E ratio of 38.55, the real estate investment trust offers a 3.06% dividend yield and has raised its dividend for 12 consecutive years. This performance reflects strong investor confidence and strategic expansions, including new joint ventures in Europe and the U.S., alongside varied analyst price targets.

Apple announced a record use of recycled materials across its products in 2025, according to its latest Environmental Progress Report. The company is also offering discounts on eligible recycled products like AirPods and other accessories when customers trade in old Apple products. This initiative aligns with Apple's environmental goals and encourages customers to participate in recycling efforts.

BW LPG's trading arm, BW Product Services, reported a gross profit of $127 million and a net profit of $98 million for Q1 2026, driven by market volatility and regional conflicts. The Middle East conflict significantly impacted performance by increasing the value of U.S.-sourced cargoes. While a large portion of the profits are currently unrealized accounting gains, they are expected to be realized gradually with physical deliveries.

Regions Financial is set to announce its first-quarter earnings, with analysts expecting a rebound after a Q4 miss. The market will focus on net interest margin stability, loan growth and credit quality, and management's ability to restore confidence. Regional bank sentiment is improving, but analyst price targets have seen recent reductions.

Robert W. Baird has lowered its price target for Elevance Health (NYSE:ELV) to $317 from $340, maintaining a "neutral" rating, which implies only a marginal upside from its previous close. This move comes amidst mixed analyst sentiment, with a consensus "Hold" rating though several firms have recently trimmed their price targets for the healthcare company. Elevance Health recently reported earnings per share of $3.33, beating estimates, but slightly missed revenue expectations.